DK572975A - Fremgangsmade til fremstilling af hidtil ukendte pyridylguanidiner - Google Patents

Fremgangsmade til fremstilling af hidtil ukendte pyridylguanidiner

Info

Publication number
DK572975A
DK572975A DK572975A DK572975A DK572975A DK 572975 A DK572975 A DK 572975A DK 572975 A DK572975 A DK 572975A DK 572975 A DK572975 A DK 572975A DK 572975 A DK572975 A DK 572975A
Authority
DK
Denmark
Prior art keywords
guanidines
pyridyl
procedure
preparing
previous
Prior art date
Application number
DK572975A
Other languages
English (en)
Other versions
DK145341B (da
DK145341C (da
Inventor
H J Petersen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of DK572975A publication Critical patent/DK572975A/da
Publication of DK145341B publication Critical patent/DK145341B/da
Application granted granted Critical
Publication of DK145341C publication Critical patent/DK145341C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
DK572975A 1974-12-20 1975-12-17 Analogifremgangsmaade til fremstilling af pyridylguanidiner DK145341C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB55209/74A GB1489879A (en) 1974-12-20 1974-12-20 N'-cyano-n'-3-pyridylguanidines
GB5520974 1974-12-20

Publications (3)

Publication Number Publication Date
DK572975A true DK572975A (da) 1976-06-21
DK145341B DK145341B (da) 1982-11-01
DK145341C DK145341C (da) 1983-03-28

Family

ID=10473276

Family Applications (1)

Application Number Title Priority Date Filing Date
DK572975A DK145341C (da) 1974-12-20 1975-12-17 Analogifremgangsmaade til fremstilling af pyridylguanidiner

Country Status (22)

Country Link
US (2) US4057636A (da)
JP (1) JPS6028819B2 (da)
AT (1) AT346357B (da)
BE (1) BE836885A (da)
CA (1) CA1067083A (da)
CH (1) CH618429A5 (da)
DD (1) DD122529A5 (da)
DE (2) DE2557438A1 (da)
DK (1) DK145341C (da)
ES (1) ES443725A1 (da)
FI (1) FI60560C (da)
FR (1) FR2294703A1 (da)
GB (1) GB1489879A (da)
IE (1) IE42141B1 (da)
IT (1) IT1062213B (da)
LU (1) LU74071A1 (da)
NL (1) NL184109C (da)
PH (1) PH12506A (da)
SE (1) SE424637B (da)
SU (1) SU683615A3 (da)
YU (1) YU39754B (da)
ZA (1) ZA757481B (da)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562066A (en) * 1978-11-03 1980-05-10 Toshihiko Okamoto N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
US4490533A (en) * 1980-12-22 1984-12-25 Merck & Co., Inc. Aminoalkyl pyridine derivatives
IE52935B1 (en) * 1981-04-15 1988-04-13 Leo Pharm Prod Ltd Pharmaceutical preparation
IE54196B1 (en) * 1981-09-10 1989-07-19 Leo Pharm Prod Ltd Chemical compounds
DK58983D0 (da) * 1983-02-11 1983-02-11 Leo Pharm Prod Ltd Farmaceutisk praeparat
JPS604120A (ja) * 1983-06-22 1985-01-10 Shionogi & Co Ltd 作用持続型ピナシジル製剤
US4617311A (en) * 1985-05-17 1986-10-14 Eli Lilly And Company Antiasthmatic method
EP0302595B1 (en) * 1987-07-07 1994-02-02 Beecham Group Plc Pinacidil for treatment of pulmonary hypertension or right heart failure
GB8800199D0 (en) * 1988-01-06 1988-02-10 Beecham Group Plc Pharmaceutical preparation
GB8801318D0 (en) * 1988-01-21 1988-02-17 Leo Pharm Prod Ltd Pharmaceutical preparations
US5244664A (en) * 1988-01-21 1993-09-14 Leo Pharmaceutical Products Ltd. Topical preparation for treatment of alopecia
WO1989010757A1 (en) * 1988-05-10 1989-11-16 Leo Pharmaceutical Products Ltd. A/S (Løvens Kemis New ophthalmic preparation for treating glaucoma
US5011837A (en) * 1988-08-09 1991-04-30 E. R. Squibb & Sons, Inc. Aryl cyanoguanidines: potassium channel activators and method of making same
NZ229828A (en) * 1988-08-09 1992-03-26 Squibb & Sons Inc Aryl cyanoguanidine derivatives and pharmaceutical compositions
US5278169A (en) * 1988-08-09 1994-01-11 E. R. Squibb & Sons, Inc. Method of treating or prevention of fibrillation of the heart
JP2884412B2 (ja) * 1988-10-21 1999-04-19 日本バイエルアグロケム株式会社 殺虫性シアノ化合物
EP0381504A3 (en) * 1989-02-03 1991-09-04 Eli Lilly And Company Improvements in and relating to guanidine derivatives
US5264445A (en) * 1989-02-03 1993-11-23 Eli Lilly And Company (-)-N"-cyano-N-3-pyridyl-N'-1,2,2-trimethylpropylguanidine
EP0407346A3 (en) * 1989-07-07 1991-10-02 Ciba-Geigy Ag Aminopyridines
US5006523A (en) * 1989-10-26 1991-04-09 E. R. Squibb & Sons, Inc. Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers
US5217982A (en) * 1990-09-25 1993-06-08 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having antihypertensive properties
US5371086A (en) * 1991-03-15 1994-12-06 The Green Cross Corporation Aminopyridine compounds
JPH05294935A (ja) * 1991-03-15 1993-11-09 Green Cross Corp:The アミノピリジン系化合物
FR2677019B1 (fr) * 1991-05-27 1994-11-25 Pf Medicament Nouvelles piperidines disubstituees-1,4, leur preparation et leur application en therapeutique.
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
IL102548A (en) * 1991-08-02 1998-08-16 Medivir Ab Use of painting derivatives in the preparation of drugs for VIH inhibition and treatment of SDIA and new compounds
KR940703666A (ko) * 1991-12-23 1994-12-12 로렌스 티. 웰츠 발기 부전증 치료에 효능있는 약제(a potent drug for treatment of erectile dysfunction)
US5262419A (en) * 1992-06-11 1993-11-16 E. R. Squibb & Sons, Inc. Method for the prophylaxis and/or treatment of ulcerative gastrointestinal conditions using a potassium channel activator
AU4530693A (en) * 1992-08-13 1994-03-15 Upjohn Company, The Cyanoguanidines as potassium channel blockers
GB9219472D0 (en) * 1992-09-15 1992-10-28 Leo Pharm Prod Ltd Chemical compounds
JPH06228100A (ja) * 1992-12-07 1994-08-16 Green Cross Corp:The 光学活性アミノピリジン誘導体およびその用途
ATE176905T1 (de) * 1993-06-11 1999-03-15 Upjohn Co Pyrimidine-cyanoguanidine als kaliumkanalblocker
US5547966A (en) * 1993-10-07 1996-08-20 Bristol-Myers Squibb Company Aryl urea and related compounds
US5633374A (en) * 1993-11-26 1997-05-27 The Upjohn Company Pyrimidine, cyanoguanidines as K-channel blockers
WO1995020579A1 (en) * 1994-01-28 1995-08-03 Pharmacia & Upjohn Company Cyanoguanidines as k-channel blockers
US5525742A (en) * 1994-06-10 1996-06-11 The Upjohn Company Azidophenylcyanoguanidines as photoaffinity probes
US5856449A (en) * 1994-11-17 1999-01-05 Pharmacia & Upjohn Company Protein affecting KATP channels
WO1998006399A1 (en) * 1996-08-15 1998-02-19 Smithkline Beecham Corporation Il-8 receptor antagonists
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
US6013668A (en) * 1997-08-13 2000-01-11 Bristol-Myers Squibb Company Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile
US6458835B2 (en) 1997-08-13 2002-10-01 Bristol-Myers Squibb Company Method of inhibiting or treating chemotherapy-induced hair loss
AU9211098A (en) * 1997-09-03 1999-03-22 American Home Products Corporation Thiourea for increasing hdl-cholesterol levels, which are useful as anti-atherosclerotic agents
US6255323B1 (en) 1999-04-09 2001-07-03 Shionogi Bioresearch Corp. Cyanoguanidine compounds
GB9908410D0 (en) 1999-04-13 1999-06-09 Pfizer Ltd Pyridines
AU4841700A (en) 1999-05-12 2000-11-21 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
US6645968B2 (en) 1999-08-03 2003-11-11 Abbott Laboratories Potassium channel openers
WO2004037789A2 (en) * 2002-10-24 2004-05-06 Merck Patent Gmbh Methylene urea derivatives as raf-kinase inhibitors
WO2007022964A2 (de) * 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
US20070250567A1 (en) * 2006-04-20 2007-10-25 Graham Philip R System and method for controlling a telepresence system
US20110009446A1 (en) * 2008-01-11 2011-01-13 Nektar Therapeutics Oligomer-guanidine class conjugates
WO2012077108A1 (en) * 2010-12-09 2012-06-14 Radikal Therapeutics Inc. Multifunctional nitroxide derivatives and uses thereof
WO2021044413A1 (en) * 2019-09-03 2021-03-11 Salzman Group Ltd. Atp-regulated potassium channel openers comprising guanidine and uses thereof
WO2023176554A1 (ja) * 2022-03-14 2023-09-21 国立大学法人東北大学 認知機能改善剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3036083A (en) * 1959-05-15 1962-05-22 Ciba Geigy Corp Certain 2-pyridyl lower alkyl guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines

Also Published As

Publication number Publication date
CH618429A5 (da) 1980-07-31
ATA936075A (de) 1978-03-15
ES443725A1 (es) 1977-04-16
AU8712775A (en) 1977-06-09
ZA757481B (en) 1977-01-26
IT1062213B (it) 1983-09-20
FI753520A (da) 1976-06-21
NL184109B (nl) 1988-11-16
SE7514153L (sv) 1976-06-21
US4057636A (en) 1977-11-08
DK145341B (da) 1982-11-01
IE42141L (en) 1976-06-20
YU316275A (en) 1982-02-28
NL7514852A (nl) 1976-06-22
DD122529A5 (da) 1976-10-12
DK145341C (da) 1983-03-28
BE836885A (fr) 1976-06-21
DE2557438A1 (de) 1976-06-24
GB1489879A (en) 1977-10-26
FR2294703A1 (fr) 1976-07-16
SU683615A3 (ru) 1979-08-30
CA1067083A (en) 1979-11-27
IE42141B1 (en) 1980-06-04
LU74071A1 (da) 1976-11-11
YU39754B (en) 1985-04-30
AT346357B (de) 1978-11-10
FI60560B (fi) 1981-10-30
PH12506A (en) 1979-04-18
JPS5186474A (da) 1976-07-29
NL184109C (nl) 1989-04-17
DE2560633C2 (da) 1988-09-08
SE424637B (sv) 1982-08-02
USRE31244E (en) 1983-05-17
JPS6028819B2 (ja) 1985-07-06
FR2294703B1 (da) 1980-06-27
FI60560C (fi) 1982-02-10
DE2557438C2 (da) 1989-01-05

Similar Documents

Publication Publication Date Title
DK572975A (da) Fremgangsmade til fremstilling af hidtil ukendte pyridylguanidiner
DK487475A (da) Fremgangsmade til fremstilling af vandkveldende polyalkylenoxid
DK392675A (da) Fremgangsmade til fremstilling af substituerede puriner
DK150155C (da) Analogifremgangsmaade til fremstilling af benzocycloamid-derivater
DK552377A (da) Fremgangsmaade til fremstilling af alfa-beskyttede oxyimino-beta-oxo-gamma-halogen-smoersyrederivater
DK321875A (da) Fremgangsmade til fremstilling af amidin-metal-komplekser
DK244875A (da) Fremgangsmade til fremstilling af chromanderivater
DK222375A (da) Fremgangsmade til fremstilling af alkyl-tert-butylethere
DK558975A (da) Fremgangsmade til fremstilling af polycarbonater
DK292475A (da) Fremgangsmade til fremstilling af derivater af 3-amino-2-hydroxy-1-phenoxy-propan
DK351875A (da) Fremgangsmade til fremstilling af 7-methoxy-6-thiatetracyliner
DK223175A (da) Fremgangsmade til fremstilling af pyridobenzodiazepinoner
DK247175A (da) Fremgangsmade til fremstilling af decahydroisoquinolin-forbindelser
DK145877C (da) Fremgangsmaade til fremstilling af alfa-6-desoxy-5-hydroxytetracyclin
DK442977A (da) Fremgangsmade til fremstilling af gamma-l-glutamyltaurin
DK409575A (da) Fremgangsmade til fremstilling af spanplader
DK154890C (da) Fremgangsmaade til fremstilling af 7beta-acylamino-7alfa-alkoxycephalosporiner
DK547675A (da) Fremgangsmade til fremstilling af 6-methyl-8beta-substituerede methylergoliner
DK344175A (da) Fremgangsmade til fremstilling af chromanderivater
DK212875A (da) Fremgangsmade til fremstilling af 5-phenyltetrazol-forbindelser
DK373475A (da) Fremgangsmade til optrekning af daser
DK197575A (da) Fremgangsmade til fremstilling af peptider
DK137539B (da) Fremgangsmade til fremstilling af 11beta-fluor-4-androsten-3-oner
DK482675A (da) Fremgangsmade til fremstilling af antibakterielt aktive forbindelser
DK159266C (da) Fremgangsmaade til fremstilling af substituerede amidinforbindelser

Legal Events

Date Code Title Description
PUP Patent expired